PI3K inhibition blocked adhesion of both ZAP-70 positive and ZAP-70 negative B-CLL and reversed enhanced adhesion induced by CD40L + IL-4, IL-6, or IL-8 (Lafarge et al., in preparation). Here, PIK3CA is linked to B-cell chronic lymphocytic leukemia.